PF-Atlas › Clinical Trials › NCT03078127
Researching the Effects of Airway Clearance Therapies in Cystic Fibrosis
Baseline · Not specified
Registry ID
NCT03078127
Phase
Not specified
Status
Completed
Drug / intervention
Baseline (Huff-Cough alone)
Sponsor
University of North Carolina, Chapel Hill
Start
2017-02-01
Enrollment
10
Locations
1
About this trial
This is a pilot study investigating the effectiveness and clinical efficacy of airway clearance therapy (ACT) in cystic fibrosis (CF). Enrolled subjects will undergo measurements of mucociliary clearance (MCC) and exhaled biomarkers at baseline and after 3 different forms of ACT: high frequency chest wall oscillatory vest, oscillatory positive expiratory pressure device, and whole-body vibration.
Explore related
Medical disclaimer. This page summarizes public trial data for NCT03078127 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.